Internet Computer ICP

Bitcoin Cash BCH

Litecoin LTC

Citius Oncology, Inc.

CTOR

Current price

1.06 USD -0.02 USD (-1.85%)

Last closed 1.10 USD

Company www.citiuspharma.com

ISIN unknown

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Exchange NASDAQ

Capitalization 116 225 520 USD

Yield for 12 month -66.88 %

10Y

15Y

CTOR

21.11.2021 - 28.11.2021

Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York.Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc. Address: 420 Lexington Avenue, New York, NY, United States, 10170

Check your investment idea

Find the best to beat the market

TSLA Tesla Motors

AAPL Apple

MSFT Microsoft

Activate

View

Activate

View

Analytics

WallStreet Target Price

–

P/E ratio

–

Dividend Yield

–

Revenue
Profit

Current Year

–

Last Year

–

Current Quarter

–

Last Quarter

–

Current Year

–

Last Year

–

Current Quarter

–

Last Quarter

–

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

EBITDA –

Operating Margin TTM –

PE Ratio –

Return On Assets TTM –

PEG Ratio –

Return On Equity TTM –

Wall Street Target Price –

Revenue TTM –

Book Value –

Revenue Per Share TTM

Dividend Share –

Quarterly Revenue Growth YOY –

Dividend Yield –

Gross Profit TTM –

Earnings per share –

Diluted Eps TTM –

Most Recent Quarter III 2023

Quarterly Earnings Growth YOY –

Profit Margin –

Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

–

5Y Dividend Growth

–

Consecutive Years

–

5Y Average Payout Ratio

–

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

Forward Annual Dividend Rate –

Ex Dividend Date –

Forward Annual Dividend Yield –

Last Split Factor –

Payout Ratio –

Last Split Date –

Dividend Date –

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

Trailing PE –

Forward PE –

Enterprise Value Revenue –

Price Sales TTM –

Enterprise Value EBITDA –

Price Book MRQ 4.55

Financials CTOR

1 year

3 years

5 years

10 years

15 years

Track key metrics for each stock in one place without the hassle

Get Premium

Results	2019	Dynamics

* The data for this period has not yet been published

0.85 USD 40.50 USD

50 Day MA 10.40 USD

Shares Short Prior Month 29 767

200 Day MA 10.91 USD

Short Ratio –

Shares Short 31 748

Short Percent –

	All Time	January, 22	February, 22	March, 22	April, 22	May, 22	June, 22
Companies with BMS 90+	+10.12%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%
Companies with BMS 60-	+10.12%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%

Similar to

Citius Oncology, Inc.